Delays in access to cancer medicines and unjustifiable price rises disadvantage patients

(ECCO-the European CanCer Organisation) Cancer patients need speedy access to new drugs and fair prices for old ones, but in many cases they are getting neither, according to studies presented at ECC2017 by researchers from the UK and Germany.